Suppr超能文献

中国一项病例对照研究中过氧化物酶体增殖物激活受体γ基因多态性与超重对糖尿病视网膜病变的相互作用

Interaction between peroxisome proliferator- activated receptor gamma polymorphism and overweight on diabetic retinopathy in a Chinese case-control study.

作者信息

Wang Yan, Wang Xin-Hua, Li Ruo-Xi

机构信息

Department of Ophthalmology, The Fourth people's Hospital of Shenyang City Shenyang 110031, Liaoning Province, PR China.

出版信息

Int J Clin Exp Med. 2015 Nov 15;8(11):21647-52. eCollection 2015.

Abstract

BACKGROUND

Peroxisome proliferator-activated receptors γ (PPAR γ) and overweight were both associated with diabetic retinopathy (DR), so the aim of this study was to investigate the association of four single nucleotide polymorphisms (SNPs) of PPAR γ with DR and additional role of gene-BMI interaction.

METHODS

A total of 500 patients with T2DM (236 men, 264 women), with a mean age of 54.3 ± 15.8 years old, were selected, including 247 diabetic retinopathy patients and 253 controls. Four SNPs were selected for genotyping in the case-control study: rs1805192, rs709158, rs3856806, rs4684847. Logistic regression model was used to examine the interaction between SNP and overweight on DR, odds ratio (OR) and 95% confident interval (95% CI) were calculated.

RESULTS

The carriers of C allele of the rs1805192 polymorphism revealed decreased DR risk than those with Pro/Pro variants (Pro/Ala+Ala/Ala versus Pro/Pro, adjusted OR (95% CI)=0.86 (0.65-0.96), P=0.012), after adjusting for covariates. We also found that obese subjects with Pro/Ala or Ala/Ala variants genotype have lowest DR risk, compared to obese subjects with Pro/Pro genotype or non- obese subjects with Pro/Ala or Ala/Ala (OR=0.40, 95% CI=0.32-0.63), after covariates adjustment.

CONCLUSIONS

Our results support an important association between rs1805192 minor allele (Ala allele) of PPAR γ and DR, the interaction analysis shown a combined effect of Ala- BMI interaction on DR.

摘要

背景

过氧化物酶体增殖物激活受体γ(PPARγ)与超重均与糖尿病视网膜病变(DR)相关,因此本研究旨在探讨PPARγ的四个单核苷酸多态性(SNP)与DR的关联以及基因-体重指数(BMI)相互作用的额外作用。

方法

共选取500例2型糖尿病患者(男性236例,女性264例),平均年龄54.3±15.8岁,其中糖尿病视网膜病变患者247例,对照组253例。在病例对照研究中选取四个SNP进行基因分型:rs1805192、rs709158、rs3856806、rs4684847。采用逻辑回归模型检验SNP与超重对DR的相互作用,计算比值比(OR)和95%置信区间(95%CI)。

结果

在校正协变量后,rs-1805192多态性的C等位基因携带者的DR风险低于Pro/Pro变异体携带者(Pro/Ala+Ala/Ala与Pro/Pro相比,校正OR(95%CI)=0.86(0.65-0.96),P=0.012)。我们还发现,在校正协变量后,与Pro/Pro基因型的肥胖受试者或Pro/Ala或Ala/Ala的非肥胖受试者相比,具有Pro/Ala或Ala/Ala变异体基因型的肥胖受试者的DR风险最低(OR=0.40,95%CI=0.32-0.63)。

结论

我们的结果支持PPARγ的rs1805192次要等位基因(Ala等位基因)与DR之间的重要关联,相互作用分析显示Ala-BMI相互作用对DR有联合效应。

相似文献

9
Interaction between peroxisome proliferator-activated receptor gamma and smoking on cardiovascular disease.
Physiol Behav. 2016 Jan 1;153:28-32. doi: 10.1016/j.physbeh.2015.10.014. Epub 2015 Oct 22.
10
Impact of Interaction Between PPAR Alpha and PPAR Gamma on Breast Cancer Risk in the Chinese Han Population.
Clin Breast Cancer. 2017 Aug;17(5):336-340. doi: 10.1016/j.clbc.2016.10.003. Epub 2016 Oct 19.

引用本文的文献

1
Evaluating lipid-lowering drug targets for full-course diabetic retinopathy.
Br J Ophthalmol. 2025 Jul 22;109(8):868-874. doi: 10.1136/bjo-2024-325771.
2
Association between gene polymorphisms and diabetic retinopathy risk: a meta-analysis.
Aging (Albany NY). 2021 Feb 1;13(4):5136-5149. doi: 10.18632/aging.202433.

本文引用的文献

1
Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes.
Acta Diabetol. 2015 Aug;52(4):701-8. doi: 10.1007/s00592-014-0711-y. Epub 2015 Jan 22.
2
Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia.
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):98-103. doi: 10.1016/j.dsx.2014.04.019. Epub 2014 Jun 4.
3
Correlation of C-reactive protein and body mass index with diabetic retinopathy in Indian population.
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):28-9. doi: 10.1016/j.dsx.2014.05.004. Epub 2014 May 29.
6
Body mass index and retinopathy in Asian populations with diabetes mellitus.
Acta Diabetol. 2015 Feb;52(1):73-80. doi: 10.1007/s00592-014-0602-2. Epub 2014 Jun 1.
10
The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy.
BMC Ophthalmol. 2012 Sep 2;12:46. doi: 10.1186/1471-2415-12-46.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验